Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/vetr.4879 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Time to replace 'No trace, wrong place' with 'Sustained exhaled carbon dioxide. Comment on Br J Anaesth 2025; 134: 248-9.
Br J Anaesth
January 2025
Department of Anaesthesia, Monash Medical Centre, Melbourne, VIC, Australia.
A few words of caution on blood purification in sepsis.
Crit Care
January 2025
Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.
What matters to mothers: A qualitative exploration of pain and recovery after cesarean section.
Acta Anaesthesiol Scand
March 2025
Department of Anesthesia and Intensive care, University Hospital of Southern Denmark, Kolding, Denmark.
Background: Fast recovery after cesarean section is vital since the mother not only has to take care of herself but also the newborn. Recovery scores are useful tools to measure and compare recovery; however, standardized questionnaires may miss in-depth patient experiences. What is important to women in the postoperative period after cesarean section can vary in different populations, making it crucial to understand the specific needs of one's own population.
View Article and Find Full Text PDFEvaluating the efficacy of near-infrared spectroscopy in cerebrovascular autoregulation measurement. Comment on Br J Anaesth 2024; 133: 550-64.
Br J Anaesth
January 2025
Department of Anaesthesiology and Intensive Therapy, Alfred Sokolowski Specialist Hospital in Walbrzych, Walbrzych, Poland.
Analyses of Adverse Drug Reactions to Fluoroquinolones in Spontaneous Reports Before and After the Referral and in Clinical Routine Cases.
Drugs R D
January 2025
Research Division, Federal Institute of Drugs and Medical Devices (BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany.
Introduction: In November 2018, the European Medicines Agency (EMA) restricted the use of fluoroquinolones (used by mouth, injections or inhalation) in the context of a referral due to long-lasting and potentially irreversible adverse drug reactions (ADRs). Fluoroquinolones should no longer be used to treat mild or moderate bacterial infections unless other antibacterials cannot be used.
Objectives: The first aim of our study was to analyze whether in the period before compared with after the referral the characteristics of spontaneous ADR reports related to fluoroquinolones differed and whether specific ADRs were more frequently reported for fluoroquinolones compared with cotrimoxazole.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!